| Authors: |
Loor A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mack KN; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA., Bauer D; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ingham A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pratt EC; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. edwin.pratt@stonybrookmedicine.edu.; Stony Brook University Cancer Center, Stony Brook, NY, USA. edwin.pratt@stonybrookmedicine.edu., Lewis JS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. lewisj2@mskcc.org.; Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA. lewisj2@mskcc.org.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. lewisj2@mskcc.org. |
